Slc26a8tm1e(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Slc26a8tm1e(EUCOMM)Wtsi |
| Name: |
solute carrier family 26, member 8; targeted mutation 1e, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:4842455 |
| Gene: |
Slc26a8 Location: Chr17:28856757-28909207 bp, - strand Genetic Position: Chr17, 14.82 cM
|
| IMPC: |
Slc26a8 gene page |
|
| Mutant Cell Lines: |
EPD0654_5_A02, EPD0654_5_A03, EPD0654_5_A04, EPD0654_5_B01, EPD0654_5_B03, EPD0654_5_E01, EPD0654_5_F01, EPD0654_5_F04, EPD0654_5_H02 |
| Germline Transmission: |
Unknown
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 28889498 of Chromosome 17 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. Insertion of this cassette creates a reporter knockout mouse. Cre expression will remove the neomycin selection cassette. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:155845, J:173534)
|
|
|
|
|
| Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
| All: |
2 reference(s) |
|